1. Home
  2. ABCL vs NMFC Comparison

ABCL vs NMFC Comparison

Compare ABCL & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • NMFC
  • Stock Information
  • Founded
  • ABCL 2012
  • NMFC 2010
  • Country
  • ABCL Canada
  • NMFC United States
  • Employees
  • ABCL N/A
  • NMFC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • NMFC Finance/Investors Services
  • Sector
  • ABCL Health Care
  • NMFC Finance
  • Exchange
  • ABCL Nasdaq
  • NMFC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • NMFC 1.2B
  • IPO Year
  • ABCL 2020
  • NMFC 2011
  • Fundamental
  • Price
  • ABCL $4.39
  • NMFC $10.39
  • Analyst Decision
  • ABCL Strong Buy
  • NMFC Hold
  • Analyst Count
  • ABCL 5
  • NMFC 2
  • Target Price
  • ABCL $8.00
  • NMFC $10.50
  • AVG Volume (30 Days)
  • ABCL 5.5M
  • NMFC 457.2K
  • Earning Date
  • ABCL 08-07-2025
  • NMFC 08-04-2025
  • Dividend Yield
  • ABCL N/A
  • NMFC 12.31%
  • EPS Growth
  • ABCL N/A
  • NMFC N/A
  • EPS
  • ABCL N/A
  • NMFC 0.77
  • Revenue
  • ABCL $32,875,999.00
  • NMFC $355,675,000.00
  • Revenue This Year
  • ABCL N/A
  • NMFC N/A
  • Revenue Next Year
  • ABCL $71.11
  • NMFC N/A
  • P/E Ratio
  • ABCL N/A
  • NMFC $13.55
  • Revenue Growth
  • ABCL N/A
  • NMFC N/A
  • 52 Week Low
  • ABCL $1.89
  • NMFC $8.84
  • 52 Week High
  • ABCL $5.82
  • NMFC $12.45
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 51.44
  • NMFC 48.52
  • Support Level
  • ABCL $4.01
  • NMFC $10.30
  • Resistance Level
  • ABCL $4.81
  • NMFC $10.47
  • Average True Range (ATR)
  • ABCL 0.36
  • NMFC 0.17
  • MACD
  • ABCL -0.05
  • NMFC 0.01
  • Stochastic Oscillator
  • ABCL 42.59
  • NMFC 86.36

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

Share on Social Networks: